These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10652423)
1. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Oskam NT; Bijleveld EH; Hulsebos TJ Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501 [TBL] [Abstract][Full Text] [Related]
4. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812 [TBL] [Abstract][Full Text] [Related]
5. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution. Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311 [TBL] [Abstract][Full Text] [Related]
6. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma. Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567 [TBL] [Abstract][Full Text] [Related]
7. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495 [TBL] [Abstract][Full Text] [Related]
8. Deletion mapping of chromosome 19 in human gliomas. von Deimling A; Nagel J; Bender B; Lenartz D; Schramm J; Louis DN; Wiestler OD Int J Cancer; 1994 Jun; 57(5):676-80. PubMed ID: 8194874 [TBL] [Abstract][Full Text] [Related]
9. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
10. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. Tada K; Shiraishi S; Kamiryo T; Nakamura H; Hirano H; Kuratsu J; Kochi M; Saya H; Ushio Y J Neurosurg; 2001 Oct; 95(4):651-9. PubMed ID: 11596960 [TBL] [Abstract][Full Text] [Related]
11. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255 [TBL] [Abstract][Full Text] [Related]
12. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Jeng YM; Hsu HC Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910 [TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. Zainuddin N; Jaafart H; Isa MN; Abdullah JM Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064 [TBL] [Abstract][Full Text] [Related]
14. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875 [TBL] [Abstract][Full Text] [Related]
15. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
16. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors. Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070 [TBL] [Abstract][Full Text] [Related]
17. Loss of constitutional heterozygosity in human astrocytomas. Van de Kelft E; De Boulle K; Willems P; Martin JJ; Selosse P; Van der Auwera B Acta Neurochir (Wien); 1992; 117(3-4):172-7. PubMed ID: 1357919 [TBL] [Abstract][Full Text] [Related]
18. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas. Jin W; Xu X; Yang T; Hua Z Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 19 in secondary glioblastomas. Nakamura M; Yang F; Fujisawa H; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 2000 Jun; 59(6):539-43. PubMed ID: 10850866 [TBL] [Abstract][Full Text] [Related]
20. Loss of 14q chromosome in oligodendroglial and astrocytic tumors. Dichamp C; Taillibert S; Aguirre-Cruz L; Lejeune J; Marie Y; Kujas M; Delattre JY; Hoang-Xuan K; Sanson M J Neurooncol; 2004 May; 67(3):281-5. PubMed ID: 15164983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]